Fact Sheet

Hint:

You can download the complete fact sheet as pdf by clicking the Download as PDF link at the top bar

The pdf combines the information under each folder tab ('About the company', 'Share', 'Key figures') to single page. All the selections made e.g. under 'Share' tab will be reflected in the pdf.

About Novartis

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas.

Company Headquarters
	Novartis International AG CH-4002 Basel Switzerland Tel: +41 61 324 11 11 Tel: +41 61 324 80 01
See more images of Novartis Basel campus

Recent media releases

8/30/2010
Novartis International BioCamp provides forum for future research and business leaders to engage in scientific innovation

8/27/2010
Novartis drug Tasigna® approved in Switzerland after fast-track review for treatment of patients with newly diagnosed Ph+ CML

8/27/2010
Novartis receives FDA approval of Tekamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure

Top products

Product	Full Year 2009 Product Sales		Therapeutic Area
Product	USD m	variance in USD	Therapeutic Area
	6,013	5%	Cardiovascular and Metabolism

	3,944	7%	Oncology

	1,469	6%	Oncology

	1,266	12%	Oncology

	1,232	39%	Neuroscience and Ophthalmics

See more product information

Awards

	DiversityInc ranks Novartis No. 7 in its Top 10 Companies for Global Diversity in 2010. In 2009, Novartis was No. 8 on this list.
	Novartis recognized in the "World's Most Innovative Companies" list by Fast Company magazine. Novartis listed as No. 8 on the overall company list, as well as No. 1 on the biotechnology sector list.
Read more about Novartis rankings and awards